Delivery Order SPE2DB24D1021-SPE2DB25FFAWE
- Not listed
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Modafinil 100 mg tablets in quantities of 30 with a ceiling value of $11,287.97. This is a firm fixed-price delivery order with no set-aside designation, awarded through competitive procurement. The contract is set to be completed by August 7, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Modafinil 100 mg tablets in 30-count packages, with a ceiling value of $13,545.60 and an ultimate completion date of September 24, 2025. This non-competitive delivery order carries firm fixed pricing and represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at...
- The Defense Logistics Agency awarded a competitive delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Modafinil 100 mg tablets in quantities of 30, with a ceiling value of $11,943.31. This delivery order represents a firm fixed price contract with a completion date of September 12, 2025, and is executed under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Modafinil 100 mg tablets in quantities of 30 at a ceiling value of $2,055.22. This non-set-aside, competitively awarded contract reflects a firm fixed-price delivery order with an ultimate completion date of August 8, 2025. The order is being fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, the company's headquarters. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $5,370.31 to AmerisourceBergen Drug Corp for the supply of Modafinil 100 mg tablets in quantities of 30 on June 3, 2025, with an ultimate completion date of June 4, 2025. This firm fixed-price delivery order represents a non-competitive set-aside and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Modafinil 100 mg tablets in quantities of 30 with a ceiling value of $1,750.25. This contract, which is a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX valued at $999,999,999.00 through December 2026), represents a non-set-aside, competitively awarded transaction. Performance will be...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Modafinil 100 mg tablets (30-count units) with a ceiling value of $4,272.66. This non-competitive delivery order reflects a firm fixed-price contract structure and represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The place of...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on September 23, 2025, for the supply of Modafinil 100 mg tablets in 30-count units. The contract is valued at $2,180.51 under a firm fixed-price arrangement with an ultimate completion date of September 24, 2025. This non-set-aside award was competitively awarded and represents a child order under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Modafinil 100 mg tablets in quantities of 30 units, with a ceiling value of $1,125.60 and firm fixed pricing. This is a non-set-aside competitive award issued as a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which carries a prime contract value of $999,999,999.00 through December 2026. The...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Modafinil 100 mg tablets in quantities of 30, with a contract ceiling value of $12,220.34. This is a firm fixed price, competitively awarded delivery order with an ultimate completion date of September 16, 2025. The award was made without a set-aside designation, reflecting open competition among qualified pharmaceutical distributors. AmerisourceBergen's performance of...
- SPE2DB24D1021Indefinite Delivery Contract
- SPE2DB24D1021-SPE2DB25FFAWEDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Modafinil 100 mg tablets (30-count units) with a contract value of $2,866.03. This non-competitive, firm fixed-price delivery order is scheduled for completion by September 19, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support Medical. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, holds a significant prime indefinite delivery contract (SPE2DX) valued at $999,999,999.00 through December 2026 that enables the supply of pharmaceutical products and medical supplies to support military healthcare programs globally. As a critical vendor within the federal medical procurement system, the company maintains a comprehensive portfolio of brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. This delivery order for modafinil, a pharmaceutical used in treating sleep disorders and fatigue, reflects the company's ongoing role in fulfilling pharmaceutical needs for Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.9k | 9/18/25 |